Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:28
12/01/21
12/01
16:28
12/01/21
16:28
CRM

Salesforce

$251.50 /

-33.51 (-11.76%)

, XOM

Exxon Mobil

$59.78 /

-0.02 (-0.03%)

, HPE

HP Enterprise

$14.20 /

-0.18 (-1.25%)

, MRK

Merck

$74.43 /

-0.43 (-0.57%)

, SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$450.52 /

-5.32 (-1.17%)

, DNUT

Krispy Kreme

$13.18 /

-1.33 (-9.17%)

, DASH

DoorDash

$161.43 /

-17.335 (-9.70%)

, COF

Capital One

$138.35 /

-2.145 (-1.53%)

, DHI

D.R. Horton

$97.76 /

+0.02 (+0.02%)

, LEN

Lennar

$108.58 /

+3.52 (+3.35%)

, SKX

Skechers

$44.56 /

-0.36 (-0.80%)

, MRNA

Moderna

$310.58 /

-42.12 (-11.94%)

, AZN

AstraZeneca

$54.88 /

+0.05 (+0.09%)

, ABUS

Arbutus Biopharma

$4.60 /

+1.4 (+43.75%)

, JNJ

Johnson & Johnson

$158.16 /

+2.2 (+1.41%)

, AMGN

Amgen

$200.66 /

+1.78 (+0.90%)

, BBW

Build-A-Bear

$21.56 /

+4.67 (+27.65%)

, GIII

G-III Apparel

$30.47 /

+0.73 (+2.45%)

, BYSI

BeyondSpring

$4.94 /

-7.825 (-61.32%)

, CTIC

CTI BioPharma

$1.62 /

-0.615 (-27.52%)

, BIRD

Allbirds

$16.04 /

-3.235 (-16.78%)

, BOX

Box

$25.84 /

+2.37 (+10.10%)

, GFS

GlobalFoundries

$66.10 /

-3.32 (-4.78%)

, AMBA

Ambarella

$204.60 /

+24.69 (+13.72%)

, ZS

Zscaler

$318.19 /

-29.02 (-8.36%)

, GCP

GCP Applied Technologies

$26.65 /

+3.295 (+14.11%)

, BALY

Bally's

$35.65 /

-2.7 (-7.04%)

, WYNN

Wynn Resorts

$76.11 /

-5.01 (-6.18%)

, CZR

Caesars

$83.16 /

-6.855 (-7.62%)

Get caught up quickly on…

ShowHide Related Items >><<
ZS Zscaler
$318.19 /

-29.02 (-8.36%)

XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

WYNN Wynn Resorts
$76.11 /

-5.01 (-6.18%)

SPY SPDR S&P 500 ETF Trust
$450.52 /

-5.32 (-1.17%)

SPX S&P 500
/

+

SKX Skechers
$44.56 /

-0.36 (-0.80%)

MRNA Moderna
$310.58 /

-42.12 (-11.94%)

MRK Merck
$74.43 /

-0.43 (-0.57%)

LEN Lennar
$108.58 /

+3.52 (+3.35%)

JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

GIII G-III Apparel
$30.47 /

+0.73 (+2.45%)

GFS GlobalFoundries
$66.10 /

-3.32 (-4.78%)

GCP GCP Applied Technologies
$26.65 /

+3.295 (+14.11%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

DASH DoorDash
$161.43 /

-17.335 (-9.70%)

CZR Caesars
$83.16 /

-6.855 (-7.62%)

CTIC CTI BioPharma
$1.62 /

-0.615 (-27.52%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

COF Capital One
$138.35 /

-2.145 (-1.53%)

BYSI BeyondSpring
$4.94 /

-7.825 (-61.32%)

BOX Box
$25.84 /

+2.37 (+10.10%)

BBW Build-A-Bear
$21.56 /

+4.67 (+27.65%)

BALY Bally's
$35.65 /

-2.7 (-7.04%)

AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

AMGN Amgen
$200.66 /

+1.78 (+0.90%)

AMBA Ambarella
$204.60 /

+24.69 (+13.72%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

12/01/21 Jefferies
Salesforce promotion of Taylor to co-CEO a positive, says Jefferies
12/01/21 Morgan Stanley
Salesforce Q3 'likely fell short' of expectations, says Morgan Stanley
12/01/21 Truist
Salesforce price target raised to $330 from $315 at Truist
12/01/21 UBS
Salesforce price target lowered to $315 from $330 at UBS
XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

11/02/21
Fly Intel: Top five analyst downgrades
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
10/21/21 Morgan Stanley
Exxon Mobil, Chevron look poised for 'catch up trade,' says Morgan Stanley
HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

12/01/21 Raymond James
HP Enterprise price target raised to $21 from $20 at Raymond James
12/01/21 Citi
Citi cuts HP Enterprise target, opens pair trade with NetApp
11/11/21 Goldman Sachs
HP Enterprise downgraded to Sell from Neutral at Goldman Sachs
10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
MRK Merck
$74.43 /

-0.43 (-0.57%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
SPX S&P 500
/

+

11/26/21 Morgan Stanley
Covid variant mutations may reduce vaccine effectiveness, says Morgan Stanley
11/26/21 Credit Suisse
Concerns over new Covid variant 'understandable,' says Credit Suisse
11/22/21 BTIG
In picking Powell, Biden went with 'safest choice,' says BTIG
08/04/21 Citi
Citi sees 10-year yield rising to 2%, cuts 'tech-heavy' U.S. to Neutral
SPY SPDR S&P 500 ETF Trust
$450.52 /

-5.32 (-1.17%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

12/01/21
Fly Intel: Top five analyst downgrades
12/01/21 Goldman Sachs
Krispy Kreme downgraded to Sell from Neutral at Goldman Sachs
11/08/21
Fly Intel: Top five analyst downgrades
11/08/21 Truist
Krispy Kreme downgraded to Hold from Buy at Truist
DASH DoorDash
$161.43 /

-17.335 (-9.70%)

12/02/21 UBS
DoorDash initiated with a Neutral at UBS
12/01/21
Fly Intel: Top five analyst upgrades
12/01/21 Gordon Haskett
Gordon Haskett sees 'compelling re-entry point,' upgrades DoorDash to Buy
12/01/21 Gordon Haskett
DoorDash upgraded to Buy from Hold at Gordon Haskett
COF Capital One
$138.35 /

-2.145 (-1.53%)

12/01/21 Baird
Capital One upgraded to Neutral after underperformance at Baird
12/01/21 Baird
Capital One upgraded to Neutral from Underperform at Baird
10/27/21 Credit Suisse
Capital One price target raised to $190 from $184 at Credit Suisse
DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

12/01/21 Goldman Sachs
D.R. Horton downgraded to Neutral from Buy at Goldman Sachs
11/17/21 Raymond James
D.R. Horton price target raised to $120 from $110 at Raymond James
11/11/21 Citi
D.R. Horton price target raised to $116 from $104 at Citi
LEN Lennar
$108.58 /

+3.52 (+3.35%)

12/01/21 Goldman Sachs
Lennar upgraded to Buy from Neutral at Goldman Sachs
11/08/21 BofA
Lennar reinstated with a Buy at BofA
10/14/21 JPMorgan
Lennar price target lowered to $127 from $143 at JPMorgan
SKX Skechers
$44.56 /

-0.36 (-0.80%)

11/02/21 Argus
Skechers downgraded to Hold from Buy at Argus
10/29/21 B. Riley
Skechers growth thesis intact despite Q3 miss, says B. Riley
10/19/21
Fly Intel: Top five analyst upgrades
MRNA Moderna
$310.58 /

-42.12 (-11.94%)

11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

11/29/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

12/02/21 Chardan
Arbutus Biopharma price target raised to $5.50 from $5 at Chardan
11/08/21 H.C. Wainwright
Arbutus Biopharma price target lowered to $8 from $10 at H.C. Wainwright
06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
AMGN Amgen
$200.66 /

+1.78 (+0.90%)

11/22/21 Mizuho
Amgen price target lowered to $194 from $222 at Mizuho
11/18/21 BMO Capital
Amgen initiated with a Market Perform at BMO Capital
11/01/21 Oppenheimer
Amgen price target lowered to $272 from $277 at Oppenheimer
10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
BBW Build-A-Bear
$21.56 /

+4.67 (+27.65%)

GIII G-III Apparel
$30.47 /

+0.73 (+2.45%)

06/08/21 B. Riley
G-III Apparel price target raised to $41 from $39 at B. Riley
06/08/21 Barclays
G-III Apparel price target raised to $30 from $27 at Barclays
03/19/21 B. Riley
G-III Apparel price target raised to $38 from $33 at B. Riley Securities
03/19/21 Barclays
G-III Apparel price target raised to $27 from $24 at Barclays
BYSI BeyondSpring
$4.94 /

-7.825 (-61.32%)

12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
12/01/21 William Blair
BeyondSpring cut to Market Perform at William Blair after CRL for plinabulin
CTIC CTI BioPharma
$1.62 /

-0.615 (-27.52%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
BIRD Allbirds
$16.04 /

-3.235 (-16.78%)

12/01/21 Morgan Stanley
Morgan Stanley says Allbirds investors may have been seeking upside
11/29/21
Fly Intel: Top five analyst initiations
11/29/21 Guggenheim
Guggenheim starts Allbirds at Buy, sees 50% potential upside
11/29/21 Guggenheim
Allbirds initiated with a Buy at Guggenheim
BOX Box
$25.84 /

+2.37 (+10.10%)

12/02/21 Berenberg
Box price target raised to $34 from $30 at Berenberg
12/01/21 Craig-Hallum
Box price target raised to $38 from $31 at Craig-Hallum
12/01/21 Morgan Stanley
Box price target raised to $30 at Morgan Stanley after 'beat and raise quarter'
12/01/21 Raymond James
Box price target raised to $30 from $29 at Raymond James
GFS GlobalFoundries
$66.10 /

-3.32 (-4.78%)

12/01/21 Morgan Stanley
GlobalFoundries target up to $68 at Morgan Stanley after 'solid' first report
12/01/21 Credit Suisse
GlobalFoundries price target raised to $80 from $75 at Credit Suisse
12/01/21 Deutsche Bank
GlobalFoundries price target raised to $78 from $75 at Deutsche Bank
11/22/21
Fly Intel: Top five analyst initiations
AMBA Ambarella
$204.60 /

+24.69 (+13.72%)

12/01/21 Colliers
Ambarella price target raised to $245 from $135 at Colliers
12/01/21 Cowen
Ambarella price target raised to $235 from $150
12/01/21 Craig-Hallum
Ambarella price target raised to $250 from $170 at Craig-Hallum
12/01/21 Morgan Stanley
Ambarella price target raised to $229 from $222 at Morgan Stanley
ZS Zscaler
$318.19 /

-29.02 (-8.36%)

12/01/21 Truist
Zscaler price target raised to $400 from $325 at Truist
12/01/21 Wedbush
Zscaler price target raised to $400 from $320 at Wedbush
12/01/21 Canaccord
Zscaler price target raised to $400 from $340 at Canaccord
12/01/21 Needham
Zscaler price target raised to $418 from $390 at Needham
GCP GCP Applied Technologies
$26.65 /

+3.295 (+14.11%)

BALY Bally's
$35.65 /

-2.7 (-7.04%)

11/09/21 KeyBanc
Bally's price target lowered to $65 from $70 at KeyBanc
10/27/21
Fly Intel: Top five analyst initiations
10/27/21 Goldman Sachs
Bally's initiated with a Neutral at Goldman Sachs
10/26/21
Fly Intel: Top five analyst upgrades
WYNN Wynn Resorts
$76.11 /

-5.01 (-6.18%)

11/10/21 Wells Fargo
Wynn Resorts price target lowered to $101 from $112 at Wells Fargo
11/10/21 Deutsche Bank
Wynn Resorts price target lowered to $131 from $140 at Deutsche Bank
11/10/21 Stifel
Wynn Resorts price target raised to $124 from $107 at Stifel
10/20/21 Morgan Stanley
Wynn Resorts price target lowered to $107 from $113 at Morgan Stanley
CZR Caesars
$83.16 /

-6.855 (-7.62%)

11/29/21 Deutsche Bank
Caesars price target lowered to $130 from $132 at Deutsche Bank
11/12/21
Fly Intel: Top five analyst initiations
11/12/21 B. Riley
B. Riley starts 'mispriced empire' Caesars with Buy, $191 target
11/12/21 B. Riley
Caesars initiated with a Buy at B. Riley
ZS Zscaler
$318.19 /

-29.02 (-8.36%)

XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

WYNN Wynn Resorts
$76.11 /

-5.01 (-6.18%)

SKX Skechers
$44.56 /

-0.36 (-0.80%)

MRNA Moderna
$310.58 /

-42.12 (-11.94%)

MRK Merck
$74.43 /

-0.43 (-0.57%)

LEN Lennar
$108.58 /

+3.52 (+3.35%)

JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

GIII G-III Apparel
$30.47 /

+0.73 (+2.45%)

GFS GlobalFoundries
$66.10 /

-3.32 (-4.78%)

GCP GCP Applied Technologies
$26.65 /

+3.295 (+14.11%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

DASH DoorDash
$161.43 /

-17.335 (-9.70%)

CZR Caesars
$83.16 /

-6.855 (-7.62%)

CTIC CTI BioPharma
$1.62 /

-0.615 (-27.52%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

COF Capital One
$138.35 /

-2.145 (-1.53%)

BYSI BeyondSpring
$4.94 /

-7.825 (-61.32%)

BOX Box
$25.84 /

+2.37 (+10.10%)

BIRD Allbirds
$16.04 /

-3.235 (-16.78%)

BBW Build-A-Bear
$21.56 /

+4.67 (+27.65%)

BALY Bally's
$35.65 /

-2.7 (-7.04%)

AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

AMGN Amgen
$200.66 /

+1.78 (+0.90%)

AMBA Ambarella
$204.60 /

+24.69 (+13.72%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

  • 03
    Nov
  • 28
    Oct
  • 19
    Aug
  • 01
    Jul
  • 20
    May
  • 16
    Apr
  • 01
    Apr
  • 09
    Feb
  • 09
    Dec
ZS Zscaler
$318.19 /

-29.02 (-8.36%)

XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

WYNN Wynn Resorts
$76.11 /

-5.01 (-6.18%)

SPX S&P 500
/

+

SKX Skechers
$44.56 /

-0.36 (-0.80%)

MRNA Moderna
$310.58 /

-42.12 (-11.94%)

MRK Merck
$74.43 /

-0.43 (-0.57%)

LEN Lennar
$108.58 /

+3.52 (+3.35%)

JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

GCP GCP Applied Technologies
$26.65 /

+3.295 (+14.11%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

DASH DoorDash
$161.43 /

-17.335 (-9.70%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

COF Capital One
$138.35 /

-2.145 (-1.53%)

BOX Box
$25.84 /

+2.37 (+10.10%)

BALY Bally's
$35.65 /

-2.7 (-7.04%)

AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

ZS Zscaler
$318.19 /

-29.02 (-8.36%)

XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

SPX S&P 500
/

+

SKX Skechers
$44.56 /

-0.36 (-0.80%)

MRNA Moderna
$310.58 /

-42.12 (-11.94%)

MRK Merck
$74.43 /

-0.43 (-0.57%)

LEN Lennar
$108.58 /

+3.52 (+3.35%)

JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

GIII G-III Apparel
$30.47 /

+0.73 (+2.45%)

GFS GlobalFoundries
$66.10 /

-3.32 (-4.78%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

DASH DoorDash
$161.43 /

-17.335 (-9.70%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

COF Capital One
$138.35 /

-2.145 (-1.53%)

BYSI BeyondSpring
$4.94 /

-7.825 (-61.32%)

BOX Box
$25.84 /

+2.37 (+10.10%)

BALY Bally's
$35.65 /

-2.7 (-7.04%)

AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

AMGN Amgen
$200.66 /

+1.78 (+0.90%)

AMBA Ambarella
$204.60 /

+24.69 (+13.72%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

ZS Zscaler
$318.19 /

-29.02 (-8.36%)

XOM Exxon Mobil
$59.78 /

-0.02 (-0.03%)

WYNN Wynn Resorts
$76.11 /

-5.01 (-6.18%)

SPY SPDR S&P 500 ETF Trust
$450.52 /

-5.32 (-1.17%)

SPX S&P 500
/

+

SKX Skechers
$44.56 /

-0.36 (-0.80%)

MRNA Moderna
$310.58 /

-42.12 (-11.94%)

MRK Merck
$74.43 /

-0.43 (-0.57%)

LEN Lennar
$108.58 /

+3.52 (+3.35%)

JNJ Johnson & Johnson
$158.16 /

+2.2 (+1.41%)

HPE HP Enterprise
$14.20 /

-0.18 (-1.25%)

GFS GlobalFoundries
$66.10 /

-3.32 (-4.78%)

DNUT Krispy Kreme
$13.18 /

-1.33 (-9.17%)

DHI D.R. Horton
$97.76 /

+0.02 (+0.02%)

DASH DoorDash
$161.43 /

-17.335 (-9.70%)

CZR Caesars
$83.16 /

-6.855 (-7.62%)

CRM Salesforce
$251.50 /

-33.51 (-11.76%)

COF Capital One
$138.35 /

-2.145 (-1.53%)

BYSI BeyondSpring
$4.94 /

-7.825 (-61.32%)

BOX Box
$25.84 /

+2.37 (+10.10%)

BIRD Allbirds
$16.04 /

-3.235 (-16.78%)

AZN AstraZeneca
$54.88 /

+0.05 (+0.09%)

AMGN Amgen
$200.66 /

+1.78 (+0.90%)

AMBA Ambarella
$204.60 /

+24.69 (+13.72%)

ABUS Arbutus Biopharma
$4.60 /

+1.4 (+43.75%)

SPY SPDR S&P 500 ETF Trust
$450.52 /

-5.32 (-1.17%)

SPX S&P 500
/

+

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:20
12/01/21
12/01
12:20
12/01/21
12:20
COF

Capital One

$142.66 /

+2.165 (+1.54%)

, LEN

Lennar

$109.64 /

+4.58 (+4.36%)

, ABUS

Arbutus Biopharma

$6.10 /

+2.9 (+90.63%)

, MRNA

Moderna

$321.88 /

-30.82 (-8.74%)

, CRM

Salesforce

$265.97 /

-19.04 (-6.68%)

, XOM

Exxon Mobil

$61.38 /

+1.58 (+2.64%)

, HPE

HP Enterprise

$14.49 /

+0.11 (+0.76%)

, MRK

Merck

$76.22 /

+1.36 (+1.82%)

, ZS

Zscaler

$327.43 /

-19.78 (-5.70%)

, UNCRY

UniCredit

$6.04 /

+0.072 (+1.21%)

, MCD

McDonald's

$249.99 /

+5.47 (+2.24%)

, MSFT

Microsoft

$338.11 /

+7.38 (+2.23%)

, STLA

Stellantis

$18.00 /

+0.855 (+4.99%)

, ME

23andMe

$8.15 /

-0.03 (-0.37%)

, IMGN

ImmunoGen

$7.10 /

+0.92 (+14.89%)

, BBW

Build-A-Bear

$22.03 /

+5.14 (+30.43%)

, GIII

G-III Apparel

$30.60 /

+0.86 (+2.89%)

, BYSI

BeyondSpring

$5.65 /

-7.11 (-55.72%)

, CTIC

CTI BioPharma

$1.81 /

-0.425 (-19.02%)

, BIRD

Allbirds

$16.44 /

-2.835 (-14.71%)

, BOX

Box

$26.30 /

+2.83 (+12.06%)

, GFS

GlobalFoundries

$67.74 /

-1.68 (-2.42%)

, AMBA

Ambarella

$221.50 /

+41.59 (+23.12%)

, CLS

Celestica

$10.14 /

-0.09 (-0.88%)

, DNUT

Krispy Kreme

$13.52 /

-0.99 (-6.82%)

, DASH

DoorDash

$175.32 /

-3.44 (-1.92%)

, DHI

D.R. Horton

$99.48 /

+1.74 (+1.78%)

Get caught up quickly on…

ShowHide Related Items >><<
ZS Zscaler
$327.43 /

-19.78 (-5.70%)

XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

UNCRY UniCredit
$6.04 /

+0.072 (+1.21%)

STLA Stellantis
$18.00 /

+0.855 (+4.99%)

MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

MRNA Moderna
$321.88 /

-30.82 (-8.74%)

MRK Merck
$76.22 /

+1.36 (+1.82%)

ME 23andMe
$8.15 /

-0.03 (-0.37%)

MCD McDonald's
$249.99 /

+5.47 (+2.24%)

LEN Lennar
$109.64 /

+4.58 (+4.36%)

IMGN ImmunoGen
$7.10 /

+0.92 (+14.89%)

HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

GIII G-III Apparel
$30.60 /

+0.86 (+2.89%)

GFS GlobalFoundries
$67.74 /

-1.68 (-2.42%)

DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

DASH DoorDash
$175.32 /

-3.44 (-1.92%)

CTIC CTI BioPharma
$1.81 /

-0.425 (-19.02%)

CRM Salesforce
$265.97 /

-19.04 (-6.68%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

CLS Celestica
$10.14 /

-0.09 (-0.88%)

BYSI BeyondSpring
$5.65 /

-7.11 (-55.72%)

BOX Box
$26.30 /

+2.83 (+12.06%)

BBW Build-A-Bear
$22.03 /

+5.14 (+30.43%)

AMBA Ambarella
$221.50 /

+41.59 (+23.12%)

ABUS Arbutus Biopharma
$6.10 /

+2.9 (+90.63%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

12/01/21
Fly Intel: Top five analyst upgrades
12/01/21 Baird
Capital One upgraded to Neutral after underperformance at Baird
12/01/21 Baird
Capital One upgraded to Neutral from Underperform at Baird
10/27/21 Credit Suisse
Capital One price target raised to $190 from $184 at Credit Suisse
LEN Lennar
$109.64 /

+4.58 (+4.36%)

12/01/21 Goldman Sachs
Lennar upgraded to Buy from Neutral at Goldman Sachs
11/08/21 BofA
Lennar reinstated with a Buy at BofA
10/14/21 JPMorgan
Lennar price target lowered to $127 from $143 at JPMorgan
ABUS Arbutus Biopharma
$6.10 /

+2.9 (+90.63%)

11/08/21 H.C. Wainwright
Arbutus Biopharma price target lowered to $8 from $10 at H.C. Wainwright
06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
MRNA Moderna
$321.88 /

-30.82 (-8.74%)

11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
CRM Salesforce
$265.97 /

-19.04 (-6.68%)

12/01/21 Jefferies
Salesforce promotion of Taylor to co-CEO a positive, says Jefferies
12/01/21 Morgan Stanley
Salesforce Q3 'likely fell short' of expectations, says Morgan Stanley
12/01/21 Truist
Salesforce price target raised to $330 from $315 at Truist
12/01/21 UBS
Salesforce price target lowered to $315 from $330 at UBS
XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

11/02/21
Fly Intel: Top five analyst downgrades
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
10/21/21 Morgan Stanley
Exxon Mobil, Chevron look poised for 'catch up trade,' says Morgan Stanley
HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

12/01/21 Raymond James
HP Enterprise price target raised to $21 from $20 at Raymond James
12/01/21 Citi
Citi cuts HP Enterprise target, opens pair trade with NetApp
11/11/21 Goldman Sachs
HP Enterprise downgraded to Sell from Neutral at Goldman Sachs
10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
MRK Merck
$76.22 /

+1.36 (+1.82%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
ZS Zscaler
$327.43 /

-19.78 (-5.70%)

12/01/21 Truist
Zscaler price target raised to $400 from $325 at Truist
12/01/21 Wedbush
Zscaler price target raised to $400 from $320 at Wedbush
12/01/21 Canaccord
Zscaler price target raised to $400 from $340 at Canaccord
12/01/21 Needham
Zscaler price target raised to $418 from $390 at Needham
UNCRY UniCredit
$6.04 /

+0.072 (+1.21%)

11/25/21 Goldman Sachs
UniCredit reinstated with a Conviction Buy at Goldman Sachs
11/09/21 HSBC
UniCredit upgraded to Buy from Hold at HSBC
11/02/21 UBS
UniCredit price target raised to EUR 14.65 from EUR 14.45 at UBS
10/26/21 Societe Generale
UniCredit price target raised to EUR 12 from EUR 10.60 at Societe Generale
MCD McDonald's
$249.99 /

+5.47 (+2.24%)

11/16/21 Argus
Wendy's downgraded to Hold at Argus after miss on Q3 comps and margins
10/28/21 Credit Suisse
McDonald's price target raised to $281 from $271 at Credit Suisse
10/28/21 Oppenheimer
McDonald's price target raised to $280 from $270 at Oppenheimer
10/28/21 JPMorgan
McDonald's price target raised to $260 from $250 at JPMorgan
MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

12/01/21 BMO Capital
UiPath price target lowered to $57 from $70 at BMO Capital
11/22/21 Wells Fargo
Wells Fargo starts Microsoft with Overweight, $400 target on 'bright future'
11/22/21 Wells Fargo
Microsoft initiated with an Overweight at Wells Fargo
11/19/21 UBS
Zoom Video price target lowered to $285 from $315 at UBS
STLA Stellantis
$18.00 /

+0.855 (+4.99%)

11/29/21 Citi
Stellantis resumed with a Buy at Citi
11/02/21 Nomura
Nomura downgrades Ford to Reduce, calls premium valuation 'hard to justify'
09/07/21 KeyBanc
Jeep micro site on Amazon points to auto sales moving online, says KeyBanc
09/03/21 Deutsche Bank
Stellantis deal 'significant opportunity' for Open Lending, says Deutsche Bank
ME 23andMe
$8.15 /

-0.03 (-0.37%)

11/14/21 Citi
23andMe downgraded to Neutral from Buy at Citi
08/16/21 Credit Suisse
23andMe initiated with an Outperform at Credit Suisse
08/16/21 Citi
23andMe price target lowered to $12 from $14 at Citi
07/13/21 Citi
23andMe initiated with a Buy at Citi
IMGN ImmunoGen
$7.10 /

+0.92 (+14.89%)

12/01/21 Jefferies
ImmunoGen upgraded to Buy at Jefferies after 'best-case data' in PROC
12/01/21 Jefferies
ImmunoGen upgraded to Buy from Hold at Jefferies
11/30/21 Piper Sandler
Piper says outlook on ImmunoGen's mirve opportunity 'largely unchanged'
11/30/21 RBC Capital
ImmunoGen price target raised to $9 from $8 at RBC Capital
BBW Build-A-Bear
$22.03 /

+5.14 (+30.43%)

GIII G-III Apparel
$30.60 /

+0.86 (+2.89%)

06/08/21 B. Riley
G-III Apparel price target raised to $41 from $39 at B. Riley
06/08/21 Barclays
G-III Apparel price target raised to $30 from $27 at Barclays
03/19/21 B. Riley
G-III Apparel price target raised to $38 from $33 at B. Riley Securities
03/19/21 Barclays
G-III Apparel price target raised to $27 from $24 at Barclays
BYSI BeyondSpring
$5.65 /

-7.11 (-55.72%)

12/01/21 William Blair
BeyondSpring cut to Market Perform at William Blair after CRL for plinabulin
12/01/21 William Blair
BeyondSpring downgraded to Market Perform from Outperform at William Blair
12/01/21 H.C. Wainwright
BeyondSpring downgraded to Neutral at H.C. Wainwright after CRL for plinabulin
12/01/21 H.C. Wainwright
BeyondSpring downgraded to Neutral from Buy at H.C. Wainwright
CTIC CTI BioPharma
$1.81 /

-0.425 (-19.02%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
BIRD Allbirds
$16.44 /

-2.835 (-14.71%)

12/01/21 Morgan Stanley
Morgan Stanley says Allbirds investors may have been seeking upside
11/29/21
Fly Intel: Top five analyst initiations
11/29/21 Guggenheim
Guggenheim starts Allbirds at Buy, sees 50% potential upside
11/29/21 Guggenheim
Allbirds initiated with a Buy at Guggenheim
BOX Box
$26.30 /

+2.83 (+12.06%)

12/01/21 Craig-Hallum
Box price target raised to $38 from $31 at Craig-Hallum
12/01/21 Morgan Stanley
Box price target raised to $30 at Morgan Stanley after 'beat and raise quarter'
12/01/21 Raymond James
Box price target raised to $30 from $29 at Raymond James
10/07/21
Fly Intel: Top five analyst downgrades
GFS GlobalFoundries
$67.74 /

-1.68 (-2.42%)

12/01/21 Morgan Stanley
GlobalFoundries target up to $68 at Morgan Stanley after 'solid' first report
12/01/21 Credit Suisse
GlobalFoundries price target raised to $80 from $75 at Credit Suisse
12/01/21 Deutsche Bank
GlobalFoundries price target raised to $78 from $75 at Deutsche Bank
11/22/21
Fly Intel: Top five analyst initiations
AMBA Ambarella
$221.50 /

+41.59 (+23.12%)

12/01/21 Colliers
Ambarella price target raised to $245 from $135 at Colliers
12/01/21 Cowen
Ambarella price target raised to $235 from $150
12/01/21 Craig-Hallum
Ambarella price target raised to $250 from $170 at Craig-Hallum
12/01/21 Morgan Stanley
Ambarella price target raised to $229 from $222 at Morgan Stanley
CLS Celestica
$10.14 /

-0.09 (-0.88%)

09/23/21 Citi
Celestica price target raised to $8.50 from $8 at Citi
05/25/21 Stifel
Plexus warning may be signal that supply constraints will worsen, says Stifel
DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

12/01/21
Fly Intel: Top five analyst downgrades
12/01/21 Goldman Sachs
Krispy Kreme downgraded to Sell from Neutral at Goldman Sachs
11/08/21
Fly Intel: Top five analyst downgrades
11/08/21 Truist
Krispy Kreme downgraded to Hold from Buy at Truist
DASH DoorDash
$175.32 /

-3.44 (-1.92%)

12/01/21 Gordon Haskett
Gordon Haskett sees 'compelling re-entry point,' upgrades DoorDash to Buy
12/01/21 Gordon Haskett
DoorDash upgraded to Buy from Hold at Gordon Haskett
11/22/21 KGI Securities
DoorDash upgraded to Outperform from Neutral at KGI Securities
DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

12/01/21 Goldman Sachs
D.R. Horton downgraded to Neutral from Buy at Goldman Sachs
11/17/21 Raymond James
D.R. Horton price target raised to $120 from $110 at Raymond James
11/11/21 Citi
D.R. Horton price target raised to $116 from $104 at Citi
ZS Zscaler
$327.43 /

-19.78 (-5.70%)

XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

STLA Stellantis
$18.00 /

+0.855 (+4.99%)

MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

MRNA Moderna
$321.88 /

-30.82 (-8.74%)

MRK Merck
$76.22 /

+1.36 (+1.82%)

ME 23andMe
$8.15 /

-0.03 (-0.37%)

MCD McDonald's
$249.99 /

+5.47 (+2.24%)

LEN Lennar
$109.64 /

+4.58 (+4.36%)

IMGN ImmunoGen
$7.10 /

+0.92 (+14.89%)

HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

GIII G-III Apparel
$30.60 /

+0.86 (+2.89%)

GFS GlobalFoundries
$67.74 /

-1.68 (-2.42%)

DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

DASH DoorDash
$175.32 /

-3.44 (-1.92%)

CTIC CTI BioPharma
$1.81 /

-0.425 (-19.02%)

CRM Salesforce
$265.97 /

-19.04 (-6.68%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

CLS Celestica
$10.14 /

-0.09 (-0.88%)

BYSI BeyondSpring
$5.65 /

-7.11 (-55.72%)

BOX Box
$26.30 /

+2.83 (+12.06%)

BIRD Allbirds
$16.44 /

-2.835 (-14.71%)

BBW Build-A-Bear
$22.03 /

+5.14 (+30.43%)

AMBA Ambarella
$221.50 /

+41.59 (+23.12%)

ABUS Arbutus Biopharma
$6.10 /

+2.9 (+90.63%)

  • 02
    Dec
  • 03
    Nov
  • 28
    Oct
  • 19
    Aug
  • 01
    Jul
  • 20
    May
  • 01
    Apr
  • 09
    Dec
ZS Zscaler
$327.43 /

-19.78 (-5.70%)

XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

UNCRY UniCredit
$6.04 /

+0.072 (+1.21%)

STLA Stellantis
$18.00 /

+0.855 (+4.99%)

MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

MRNA Moderna
$321.88 /

-30.82 (-8.74%)

MRK Merck
$76.22 /

+1.36 (+1.82%)

ME 23andMe
$8.15 /

-0.03 (-0.37%)

MCD McDonald's
$249.99 /

+5.47 (+2.24%)

LEN Lennar
$109.64 /

+4.58 (+4.36%)

HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

DASH DoorDash
$175.32 /

-3.44 (-1.92%)

CRM Salesforce
$265.97 /

-19.04 (-6.68%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

BOX Box
$26.30 /

+2.83 (+12.06%)

ZS Zscaler
$327.43 /

-19.78 (-5.70%)

XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

UNCRY UniCredit
$6.04 /

+0.072 (+1.21%)

STLA Stellantis
$18.00 /

+0.855 (+4.99%)

MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

MRNA Moderna
$321.88 /

-30.82 (-8.74%)

ME 23andMe
$8.15 /

-0.03 (-0.37%)

MCD McDonald's
$249.99 /

+5.47 (+2.24%)

LEN Lennar
$109.64 /

+4.58 (+4.36%)

HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

GIII G-III Apparel
$30.60 /

+0.86 (+2.89%)

GFS GlobalFoundries
$67.74 /

-1.68 (-2.42%)

DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

DASH DoorDash
$175.32 /

-3.44 (-1.92%)

CRM Salesforce
$265.97 /

-19.04 (-6.68%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

BYSI BeyondSpring
$5.65 /

-7.11 (-55.72%)

BOX Box
$26.30 /

+2.83 (+12.06%)

BIRD Allbirds
$16.44 /

-2.835 (-14.71%)

AMBA Ambarella
$221.50 /

+41.59 (+23.12%)

ABUS Arbutus Biopharma
$6.10 /

+2.9 (+90.63%)

ZS Zscaler
$327.43 /

-19.78 (-5.70%)

XOM Exxon Mobil
$61.38 /

+1.58 (+2.64%)

MSFT Microsoft
$338.11 /

+7.38 (+2.23%)

MRNA Moderna
$321.88 /

-30.82 (-8.74%)

MRK Merck
$76.22 /

+1.36 (+1.82%)

ME 23andMe
$8.15 /

-0.03 (-0.37%)

MCD McDonald's
$249.99 /

+5.47 (+2.24%)

LEN Lennar
$109.64 /

+4.58 (+4.36%)

HPE HP Enterprise
$14.49 /

+0.11 (+0.76%)

GFS GlobalFoundries
$67.74 /

-1.68 (-2.42%)

DNUT Krispy Kreme
$13.52 /

-0.99 (-6.82%)

DHI D.R. Horton
$99.48 /

+1.74 (+1.78%)

DASH DoorDash
$175.32 /

-3.44 (-1.92%)

CRM Salesforce
$265.97 /

-19.04 (-6.68%)

COF Capital One
$142.66 /

+2.165 (+1.54%)

BYSI BeyondSpring
$5.65 /

-7.11 (-55.72%)

BOX Box
$26.30 /

+2.83 (+12.06%)

BIRD Allbirds
$16.44 /

-2.835 (-14.71%)

AMBA Ambarella
$221.50 /

+41.59 (+23.12%)

ABUS Arbutus Biopharma
$6.10 /

+2.9 (+90.63%)

Recommendations
Zscaler price target raised to $400 from $325 at Truist » 09:20
12/01/21
12/01
09:20
12/01/21
09:20
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Truist analyst Joel…

Truist analyst Joel Fishbein raised the firm's price target on Zscaler to $400 from $325 and keeps a Buy rating on the shares after its Q1 earnings beat. The company continued its strong momentum with another "impressive beat" on top and bottom lines, showing strength in the enterprise segment as its streamlined go-to-market efforts generate increased new logos, the analyst tells investors in a research note. Fishbein adds that Zscaler's newer products like ZDX and ZCP are starting to drive customer growth in addition to increased upsell opportunity.

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

12/01/21 Wedbush
Zscaler price target raised to $400 from $320 at Wedbush
12/01/21 Canaccord
Zscaler price target raised to $400 from $340 at Canaccord
12/01/21 Needham
Zscaler price target raised to $418 from $390 at Needham
12/01/21 Morgan Stanley
Zscaler price target raised to $330 from $275 at Morgan Stanley
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Conference/Events
UBS technology analysts to hold an analyst/industry conference call » 07:55
12/01/21
12/01
07:55
12/01/21
07:55
CRM

Salesforce

$285.03 /

-11.56 (-3.90%)

, ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Technology Analysts…

Technology Analysts provide a recap of salesforce.com and Zscaler reported earnings on an Analyst/Industry conference call to be held on December 1 at 8:30 am.

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

12/01/21 Truist
Salesforce price target raised to $330 from $315 at Truist
12/01/21 UBS
Salesforce price target lowered to $315 from $330 at UBS
12/01/21 Deutsche Bank
Salesforce earnings selloff a buying opportunity, says Deutsche Bank
12/01/21 Mizuho
Salesforce price target lowered to $350 from $360 at Mizuho
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

12/01/21 Wedbush
Zscaler price target raised to $400 from $320 at Wedbush
12/01/21 Canaccord
Zscaler price target raised to $400 from $340 at Canaccord
12/01/21 Needham
Zscaler price target raised to $418 from $390 at Needham
12/01/21 Morgan Stanley
Zscaler price target raised to $330 from $275 at Morgan Stanley
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

Recommendations
Zscaler price target raised to $400 from $320 at Wedbush » 07:45
12/01/21
12/01
07:45
12/01/21
07:45
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Wedbush analyst Daniel…

Wedbush analyst Daniel Ives raised the firm's price target on Zscaler to $400 from $320 and keeps an Outperform rating on the shares. The analyst notes Zscaler delivered 'another jaw dropper quarter," with revenue growth of 62% blowing away Street estimates. Ives believes Zscaler looks to be "in the driver's seat" on the cloud cyber security shift over the next decade and the current IT backdrop has only accelerated its ability to capture it. In his opinion, Zscaker is the best pure play in the cloud security arena, which he believes is still in the very early innings of taking off with overall hybrid cloud workloads poised to meaningfully accelerate over the coming years, and in this climate could see some strategic deals moved forward as the shift to cloud outside the firewall is catalyzing a handful of key sales cycles.

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

12/01/21 Canaccord
Zscaler price target raised to $400 from $340 at Canaccord
12/01/21 Needham
Zscaler price target raised to $418 from $390 at Needham
12/01/21 Morgan Stanley
Zscaler price target raised to $330 from $275 at Morgan Stanley
12/01/21 BMO Capital
Zscaler price target raised to $415 from $315 at BMO Capital
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Recommendations
Zscaler price target raised to $400 from $340 at Canaccord » 07:35
12/01/21
12/01
07:35
12/01/21
07:35
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Canaccord analyst T.…

Canaccord analyst T. Michael Walkley raised the firm's price target on Zscaler to $400 from $340 and keeps a Buy rating on the shares. The analyst believes the company is benefiting from numerous tailwinds including cloud migration, adoption of Zero Trust principles, and the rapid growth in targeted breaches and ransomware attacks. He believes the company is poised to continue to gain share as a long-term disruptive technology, and he views the stock as a core long-term holding.

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

12/01/21 Needham
Zscaler price target raised to $418 from $390 at Needham
12/01/21 Morgan Stanley
Zscaler price target raised to $330 from $275 at Morgan Stanley
12/01/21 BMO Capital
Zscaler price target raised to $415 from $315 at BMO Capital
12/01/21 Baird
Zscaler price target raised to $415 from $325 at Baird
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Recommendations
Zscaler price target raised to $418 from $390 at Needham » 07:32
12/01/21
12/01
07:32
12/01/21
07:32
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Needham analyst Alex…

Needham analyst Alex Henderson raised the firm's price target on Zscaler to $418 from $390 and keeps a Strong Buy rating on the shares. The company's Q1 results delivered "exceptional" growth, with accelerating Revenues, strong ARR and RPO growth, and strong Net Retention/upsell/cross-sell amid strengthening demand in every vertical and geography, the analyst tells investors in a research note. Henderson further cites Zscaler's earnings call highlighting the "rapidly broadening" product suite, the success of new features enabled by the micro-services Cloud Native architecture, and the increasing AI- driven threat intelligence capabilities.

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

12/01/21 Morgan Stanley
Zscaler price target raised to $330 from $275 at Morgan Stanley
12/01/21 BMO Capital
Zscaler price target raised to $415 from $315 at BMO Capital
12/01/21 Baird
Zscaler price target raised to $415 from $325 at Baird
12/01/21 Wolfe Research
Zscaler price target raised to $400 from $325 at Wolfe Research
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Recommendations
Zscaler price target raised to $330 from $275 at Morgan Stanley » 07:21
12/01/21
12/01
07:21
12/01/21
07:21
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Morgan Stanley analyst…

Morgan Stanley analyst Keith Weiss raised the firm's price target on Zscaler to $330 from $275 and keeps an Equal Weight rating on the shares after the company "delivered another strong set of results" in fiscal Q1, including total billings that were up 71% year-over-year and 22% ahead of consensus. With revenue growth accelerating as the company surpassed $1B in Annual Recurring Revenue, the "pieces are in place to reach $5B+ ARR longer term," said Weiss, but he sees much of the growth opportunity as likely priced in at the stock's current valuation.

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

12/01/21 BMO Capital
Zscaler price target raised to $415 from $315 at BMO Capital
12/01/21 Baird
Zscaler price target raised to $415 from $325 at Baird
12/01/21 Wolfe Research
Zscaler price target raised to $400 from $325 at Wolfe Research
12/01/21 Deutsche Bank
Zscaler price target raised to $430 from $400 at Deutsche Bank
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Recommendations
Zscaler price target raised to $415 from $315 at BMO Capital » 07:14
12/01/21
12/01
07:14
12/01/21
07:14
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

BMO Capital analyst Keith…

BMO Capital analyst Keith Bachman raised the firm's price target on Zscaler to $415 from $315 and keeps an Outperform rating on the shares. The company's Q1 earnings beat was "impressive" with 68% billings growth, 83% CRPO growth, and 36% free cash flow margin, the analyst tells investors in a research note. Bachman adds that while the stock's valuation is "rich on every metric", he believes that its technology leadership, large potential total addressable market, and durable growth rate warrant a premium valuation.

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

12/01/21 Baird
Zscaler price target raised to $415 from $325 at Baird
12/01/21 Wolfe Research
Zscaler price target raised to $400 from $325 at Wolfe Research
12/01/21 Deutsche Bank
Zscaler price target raised to $430 from $400 at Deutsche Bank
12/01/21 UBS
Zscaler price target raised to $380 from $295 at UBS
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Recommendations
Zscaler price target raised to $415 from $325 at Baird » 07:03
12/01/21
12/01
07:03
12/01/21
07:03
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Baird analyst Jonathan…

Baird analyst Jonathan Ruykhaver raised the firm's price target on Zscaler to $415 from $325 and keeps an Outperform rating on the shares. The analyst said management commentary remains positive across the board, with the company seeing adoption of the broader platform of solutions being driven by security/network transformation initiatives. He sees the company as well positioned around secular trends like Zero Trust and continues to like the long-term story.

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

12/01/21 Wolfe Research
Zscaler price target raised to $400 from $325 at Wolfe Research
12/01/21 Deutsche Bank
Zscaler price target raised to $430 from $400 at Deutsche Bank
12/01/21 UBS
Zscaler price target raised to $380 from $295 at UBS
12/01/21 Mizuho
Zscaler price target raised to $400 from $385 at Mizuho
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.